What types of Candida infections should be included when evaluating breakthrough infections during posaconazole prophylaxis?

Antimicrob Agents Chemother. 2013 Jun;57(6):2905. doi: 10.1128/AAC.00189-13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antifungal Agents / pharmacokinetics*
  • Drug Monitoring*
  • Female
  • Fungi / drug effects*
  • Humans
  • Male
  • Mycoses / blood*
  • Mycoses / prevention & control*
  • Triazoles / pharmacokinetics*

Substances

  • Antifungal Agents
  • Triazoles